1. Pure beta minus emitter.
2. Medium/high energy (>1 meV).
3. Effective half-life = moderately long, e.g., days.
4. High target:nontarget ratio.
5. Minimal radiation dose to patient and Nuclear Medicine personnel
7. Inexpensive, readily available radiopharmaceutical.
8. Simple preparation and quality control if manufactured in house.